<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04347044</url>
  </required_header>
  <id_info>
    <org_study_id>BLVR_PR</org_study_id>
    <nct_id>NCT04347044</nct_id>
  </id_info>
  <brief_title>The Effect of Pulmonary Rehabilitation on Bronchoscopic Volume Reduction Process Success</brief_title>
  <official_title>The Effect of Pulmonary Rehabilitation on Bronchoscopic Volume Reduction Process Success</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Istanbul Medipol University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Istanbul Medipol University Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The data of patients undergoing bronchoscopic volume reduction procedure will be analyzed
      retrospectively. Patients will be divided into two groups as patients with and without
      Pulmonary Rehabilitation before the procedure, and changes in functional levels of patients
      will be compared.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The data of patients who underwent bronchoscopic volume reduction between January 2013 and
      March 2019 will be examined.

      Patients will be divided into two groups as pulmonary rehabilitation applied (PR group) and
      not applied (Control group) before the procedure.

      Changes in the parameters of initial and rehabilitation follow-up will be examined.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">January 1, 2013</start_date>
  <completion_date type="Anticipated">September 1, 2020</completion_date>
  <primary_completion_date type="Actual">March 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Six minute walking test</measure>
    <time_frame>20 minutes</time_frame>
    <description>The test was conducted in a 30-meter corridor in line with American Thoracic Society (ATS) guidelines. Patients were asked to walk as far as they can. Prior to and following the test, oxygen saturation, heart rate and Borg fatigue rating were measured, and the walking distance were recorded</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pulmonary Function Tests</measure>
    <time_frame>15 minutes</time_frame>
    <description>PFTs were performed by using the Sensormedics model 2400 (Yorba Linda, CA, USA) spirometry device, and according to the American Thoracic Society (ATS) guidelines</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Carbonmonoxide diffusion test</measure>
    <time_frame>15 minutes</time_frame>
    <description>It will performed in the pulmonary function test laboratory using Cosmed Quark PFT (USA) with single-breath technique</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">80</enrollment>
  <condition>Emphysema</condition>
  <condition>Pulmonary Rehabilitation</condition>
  <condition>Bronchoscopic Lung Volume Reduction</condition>
  <arm_group>
    <arm_group_label>Pulmonary Rehabilitation Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Optimal medication and clinical follow-up plus Pulmonary rehabiltation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-Pulmonary Rehabilitation Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Optimal medication and clinical follow-up</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Pulmonary Rehabilitation</intervention_name>
    <description>Exercise training+ Optimal medication and clinical follow-up</description>
    <arm_group_label>Pulmonary Rehabilitation Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Standart care</intervention_name>
    <description>Optimal medication and clinical follow-up</description>
    <arm_group_label>Non-Pulmonary Rehabilitation Group</arm_group_label>
    <arm_group_label>Pulmonary Rehabilitation Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Between the ages of 18-75

          -  Patients with a diagnosis of emphysema and bronchoscopic procedures

        Exclusion Criteria:

        â€¢ Patients who develop complications related to the procedure after bronchoscopic
        procedure.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>April 13, 2020</study_first_submitted>
  <study_first_submitted_qc>April 13, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 15, 2020</study_first_posted>
  <last_update_submitted>July 27, 2020</last_update_submitted>
  <last_update_submitted_qc>July 27, 2020</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Saglik Bilimleri Universitesi</investigator_affiliation>
    <investigator_full_name>esra pehlivan</investigator_full_name>
    <investigator_title>Principle investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Emphysema</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

